COMMUNIQUÉS West-GlobeNewswire

Les actionnaires de Valneva approuvent toutes les résolutions recommandées par le directoire à l’Assemblée Générale du Groupe
28/06/2019
Les actionnaires de Valneva approuvent toutes les résolutions recommandées par le directoire à l’Assemblée Générale du Groupe Saint Herblain (France), 28 juin, 2019 – Valneva SE (“Valneva” ou “le Groupe”), société de [...]
Oasmia announces change of CEO
28/06/2019
Sven Rohmann, MD PhD MBA, has today been appointed as acting CEO of Oasmia Pharmaceutical AB. He assumes his new role July 1, 2019. Since March 2019 Sven Rohmann has been a member of the Board of Oasmia and since April [...]
The Board of Oasmia has decided to report certain transactions to the Swedish Economic Crime Authority and to appoint a special examiner
28/06/2019
The Board of Oasmia has decided to report certain suspicious transactions that has been made by the company during several years to the Swedish Economic Crime Authority. In connection with a tax audit in Oasmia that [...]
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2018 – April 30, 2019
28/06/2019
EVENTS IN FOURTH QUARTER Private placement of approximately MSEK 165 before issue expenses carried out New Board of Directors elected at Extraordinary General Meeting on March 19 New Board initiates review of the [...]
Progenics Pharmaceuticals Details Recent Good Faith Efforts to Settle with Velan Capital
28/06/2019
Velan Rebuffed Very Reasonable Offer that Included a One Year Standstill, Designating Two New Independent Directors and an Incumbent Director Not Standing for Re-election in 2020 Despite Progenics’ Repeated Settlement [...]
Allena Pharmaceuticals Announces $10.0 Million Registered Direct Offering of Common Stock
28/06/2019
NEWTON, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Calciphylaxis Clinical Study Expands to the United Kingdom
28/06/2019
SCOTTSDALE, Ariz., June 27, 2019 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) approved a clinical trial application for medical centers in [...]
United Cannabis Trade Association Support $30,000 Fines Imposed on Unlicensed Operators
28/06/2019
Budget trailer bill allows for increased fines in effort to curb rampant illegal activity LOS ANGELES, June 27, 2019 (GLOBE NEWSWIRE) -- California Legislature today approved additional fines and penalties that can be [...]
Chi-Med Announces Secondary Offering of American Depositary Shares
27/06/2019
LONDON, June 27, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announces that Hutchison Healthcare Holdings Limited (“HHHL”), the largest shareholder of Chi-Med and a subsidiary [...]
Cytori Announces New Annual Stockholders Meeting Date for July 11
27/06/2019
Annual Meeting Adjourned to Provide Additional Time to Obtain Approval of Key Business SAN DIEGO, June 27, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) today announced that it reconvened its annual [...]
Evolve Treatment Centers Funds DBT Training for Staff
27/06/2019
Evolve sends clinicians to a five-day Dialectical Behavior Therapy training by Behavioral Tech LOS ANGELES, June 27, 2019 (GLOBE NEWSWIRE) -- Evolve Treatment Centers for Teens sent seven clinicians to a five-day [...]
Globus Medical Appoints Keith Pfeil as Senior Vice President and CFO
27/06/2019
AUDUBON, Pa., June 27, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the appointment of Keith W. Pfeil as its Senior Vice President and Chief [...]
Biocryst Begins Enrollment of Phase 1 Trial of BCX9930, an Oral Factor D Inhibitor for Complement-Mediated Diseases
27/06/2019
—Data expected in Q4 2019— —BCX9930 showed high potency, specificity, suppression of hemolysis and wide safety margin in preclinical studies— RESEARCH TRIANGLE PARK, N.C., June 27, 2019 (GLOBE NEWSWIRE) -- BioCryst [...]
Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled IL-12 with Libtayo® (cemiplimab-rwlc) to Treat Patients with Recurrent Glioblastoma
27/06/2019
Phase 2 trial will enroll approximately 30 patients and evaluate both safety and efficacy BOSTON, June 27, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced [...]
b-2Cool’s U.S. Strategy Extinguishes Fires to Reshape Native Type II Collagen Market
27/06/2019
ANN ARBOR, Mich., June 27, 2019 (GLOBE NEWSWIRE) -- Bioiberica’s entry into the U.S. market for its native (undenatured) type II collagen, b-2Cool, through exclusive distributer Berg Nutrition, was initially met with [...]
Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments
27/06/2019
-- Achieved Fourth Quarter Revenue of $17.1 Million, an Increase of 146% Compared to Prior Year Quarter -- -- Generated Income From Continuing Operations During the Fourth Quarter of Fiscal 2019 -- -- Increasing Demand [...]
Homology Medicines Announces Leadership Updates
27/06/2019
- Sam Rasty, Ph.D., Departs as Chief Operating Officer to Lead an Emerging Biotech - BEDFORD, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced [...]
Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-810, for Treatment of Ornithine Transcarbamylase (OTC) Deficiency
27/06/2019
SAN DIEGO, June 27, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics towards rare, liver and [...]
Verrica Pharmaceuticals Enrolls First Patient in Phase 2 Trial of VP-102 for the Treatment of External Genital Warts
27/06/2019
WEST CHESTER, Pa., June 27, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that [...]

Pages